From: The emerging roles and functions of circular RNAs and their generation
CircRNA | Biological functions | miRNA | Targets | Cell type | Ref |
---|---|---|---|---|---|
CDR1as | Neural development Insulin secretion Myocardial infarction Promotes proliferation Anti-oncogenic Promotes proliferation Promotes proliferation/metastasis Osteoblastic differentiation | miR-7/− 671 miR-7 miR-7 miR-876-5p miR-7/−135a miR-7 miR-7 miR-7 | Fos Pax6, Myrip PARP, SP1 MAGE-A P21 CCNE1, PIK3CD, EGFR HOXB13 GDF5 | Neural tissue Islet cells Cardiomyocytes ESCC Bladder cancer NSCLC ESCC PDLSC | |
SRY | Sex-determining | miR-138 | Â | Testis | [16] |
circBIRC6 | Pluripotency maintenance | miR-34a/−145 | NANOG, OCT4, SOX2 | hESCs, iPSCs | [36] |
circHIPK3 | Promotes proliferation | miR-124/− 152/−193a/−29a/−29b/− 338/− 379/− 584/− 654 | IL6R, DLX2 | Cancer tissues | |
Inhibits cancer progression β-cell function Promotes proliferation Promotes proliferation/migration Promotes proliferation/migration Promotes proliferation | miR-558 miR-124-3p/338-3p miR-30a-3p miR-124 miR-7 miR-124 | HPSE Slc2a2, Akt1, Mtpn FZD4, WNT2, VEGF-C AQP3 FAK, IGF1R, EGFR ROCK1, CDK6 | Bladder cancer β-cells Retinal endothelial cells HCC CRC Gallbladder cancer | ||
circWDR77 | Promotes proliferation | miR-124 | FGF2 | VSMC | [43] |
circNT5E | Promotes cancer progression | miR-422a | PIK3CA, NT5E | Glioblastoma | [45] |
circZFR | Promotes cancer progression Promotes cancer progression Promotes cancer progression Inhibits cancer progression | miR-3619-5p miR-4302 miR-1261 miR-130a/−107 | CTNNB1 ZNF121 C8orf4 PTEN | HCC Lung cancer PTC Gastric Cancer | |
circTCF25 | Promotes cancer progression | miR-103a-3p/− 107 | CDK6 | Bladder carcinoma | [49] |
Hsa_circ_0008039 (circPRKAR1B) | Promote proliferation/migration | miR-432-5p | E2F3 | Breast cancer cells | [51] |
circITCH | Inhibits proliferation Inhibits cancer progression Inhibits cancer progression Inhibits cancer progression | miR-214 miR-17/− 224 miR-22-3p miR-145 | ITCH/CTNNB1 P21, PTEN CBL/CTNNB1 RASA1 | CRC Bladder cancer Papillary thyroid cancer Ovarian cancer | |
Hsa_circ_0002052 (circPAPPA) | Inhibits cancer progression | miR-1205 | APC2 | Osteosarcoma | [56] |
circMYLK | Promotes cancer progression | miR-29a | LAMC, TRAF4 | PC-a | [58] |
circRNA_0084043 (circADAM9) | Promotes cancer progression | miR-153-3p | SNAIL | melanoma | [59] |
circIRAK3 | Promote migration/invasion | miR-3607 | FOXC1 | Breast cancer cells | [60] |
circNASP | Promotes cancer progression | miR-1253 | FOXF1 | Osteosarcoma | [61] |
circMAN2B2 | Promotes proliferation/migration | miR-1275 | FOXK1 | Lung cancer | [62] |
circSHKBP1 | Promotes angiogenesis | miR-544a/− 379 | FOXP1, FOXP2 | Endothelial cells | [63] |
circSMAD2 | Inhibits EMT | miR-629 | TRIM33 | HCC | [64] |
circFOXO3 | Inhibits cancer progression | miR-155 | FOXO3 | NSCLC | [65] |
circFGFR4 | Myoblast differentiation | miR-107 | WNT3A | Bovine myoblast | [67] |
circSVIL | Myoblast differentiation | miR-203 | MEF2C, JUN | Chicken myoblast | [68] |
circZC3H4 | Macrophage activation | miR-212 | ZC3H4 | Alveolar macrophage | [75] |
circHIPK2 | Astrocyte activation ER stress | miR-124 miR-506-3p | SIGMAR1 SIGMAR1 | Astrocyte HPF-a | |
circHECTD1 | Inhibits astrocyte activation | miR-142 | TIPARP | Brain | [78] |
circGRB10 | Inhibits apoptosis | miR-328-5p | ERBB2 | NP cells | [79] |
Hsa_circ_0043256 (circACACA) | Induced apoptosis | miR-1252 | ITCH | NSCLC | [80] |
circDLGAP4 | Ameliorates ischemic stroke | miR-143 | HECTD1 | Brain tissue | [82] |
circVMA21 | Against IDD | miR-200c | XIAP | NP cells | [83] |
circZNF609 | Retinal neurodegeneration Vascular dysfunction Myoblast differentiation | miR-615 miR-615 miR-194-5p | METRN MEF2A BCLAF1 | RGC Vascular endothelial C2C12 | |
circPVT1 | Promotes proliferation | miR-497-5p | Aurka, Bub1, mKi67 | HNSCC | [117] |
circMTO1 | Inhibits cancer progression | miR-9 | P21 | HCC | [118] |
circITGA7 | Inhibits proliferation/metastasis | miR-370-3p | NF1 | CRC | [119] |
circACTA2 | VSMC contraction | miR-548f-5p | SMA | HASMC | [120] |
circCCDC66 | Promotes cancer progression | miR-33b/− 93/− 185 | DNMT3B, MYC, EZH2, | CRC | [121] |
circFBLIM1 | Promotes cancer progression | miR-346 | FBLIM1 | HCC | [122] |
circATP2B1 | Promotes invasion | miR-204-3p | FN1 | CCRCC | [123] |
circLARP4 | Inhibits proliferation/invasion | miR-424-5p | LATS1 | Gastric cancer | [124] |
Hsa_circ_0000799 (circBPTF) | Promotes cancer progression | miR-31-5p | RAB27A | Bladder cancer | [125] |
circRNA_000203 (circMYO9A) | Promotes fibrosis | miR-26b-5p | Col1a2, Col3a1, SMA, CTGF | Cardiac fibroblast | [126] |
circRNA_8924 (circC1orf116) | Promotes cancer progression | miR-518d-5p/− 519-5p | CBX8 | Cervical cancer cells | [127] |
circRNA_008913 (circADAT1) | Reduces carcinogenesis | miR-889 | DAB2IP | HaCaT | [128] |